ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX)

46.315
-1.86
(-3.85%)
終了 1月11日 6:00AM
46.315
0.015
(0.03%)
取引時間後: 8:41AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
46.315
買値
45.80
売値
49.67
出来高
451,541
46.00 日の範囲 48.865
37.55 52 週間の範囲 64.98
時価総額
前日終値
48.17
始値
48.00
時刻
1
@
46
最終取引時間
財務取引量
US$ 21,461,586
VWAP
47.5297
平均取引量 (3 か月)
230,288
発行済株式数
63,905,198
配当利回り
-
PER
-67.12
1 株当たり利益 (EPS)
-0.69
歳入
-
純利益
-44.08M

MoonLake Immunotherapeutics について

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

セクター
Blank Checks
業界
Pharmaceutical Preparations
ウェブサイト
本社
Grand Cayman, Cym
設立
2020
MoonLake Immunotherapeutics is listed in the Blank Checks sector of the ナスダック市場 with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was US$48.17. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of US$ 37.55 to US$ 64.98.

MoonLake Immunotherapeut... currently has 63,905,198 shares in issue. The market capitalisation of MoonLake Immunotherapeut... is US$3.08 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -67.12.

MLTX 最新ニュース

MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis suppurativa (HS), Phase 2 LEDA trial in palmoplantar...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term...

MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-7.245-13.526885735653.5655.0146.353447050.4923229CS
4-7.555-14.024503434253.8758.2646.329173952.1459413CS
12-1.765-3.6709650582448.0858.2645.2423028851.12069437CS
261.3252.9450989108744.9958.2639.3629639249.37712531CS
52-12.485-21.232993197358.864.9837.5535064548.6271828CS
15633.945274.41390460812.3764.984.2534378443.13745243CS
26033.945274.41390460812.3764.984.2534378443.13745243CS

MLTX - Frequently Asked Questions (FAQ)

What is the current MoonLake Immunotherapeut... share price?
The current share price of MoonLake Immunotherapeut... is US$ 46.315
How many MoonLake Immunotherapeut... shares are in issue?
MoonLake Immunotherapeut... has 63,905,198 shares in issue
What is the market cap of MoonLake Immunotherapeut...?
The market capitalisation of MoonLake Immunotherapeut... is USD 3.08B
What is the 1 year trading range for MoonLake Immunotherapeut... share price?
MoonLake Immunotherapeut... has traded in the range of US$ 37.55 to US$ 64.98 during the past year
What is the PE ratio of MoonLake Immunotherapeut...?
The price to earnings ratio of MoonLake Immunotherapeut... is -67.12
What is the reporting currency for MoonLake Immunotherapeut...?
MoonLake Immunotherapeut... reports financial results in USD
What is the latest annual profit for MoonLake Immunotherapeut...?
The latest annual profit of MoonLake Immunotherapeut... is USD -44.08M
What is the registered address of MoonLake Immunotherapeut...?
The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104
What is the MoonLake Immunotherapeut... website address?
The website address for MoonLake Immunotherapeut... is moonlaketx.com
Which industry sector does MoonLake Immunotherapeut... operate in?
MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.56M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

最近閲覧した銘柄

Delayed Upgrade Clock